34 results  1 of 2 

1 Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination
Ji-Won Kim, Ju-Yang Jung, Chang-Hee Suh, Young-Min Ye, Hyoun-Ah Kim
J Korean Med Sci.2023;38(32):e247.  Published online 2023 July 26     DOI: http://dx.doi.org/10.3346/jkms.2023.38.e247
      
2 Current clinical application of dantrolene sodium
Hong Seuk Yang, Jae Moon Choi, Junyong In, Tae-yun Sung, Yong Beom Kim, Shofina Sultana
Anesth Pain Med.2023;18(3):220-232.   Published online 2023 July 26     DOI: http://dx.doi.org/10.17085/apm.22260
      
3 Characteristics and usefulness of transabdominal ultrasonography in immune-mediated colitis
Kensuke Sakurai, Takehiko Katsurada, Mutsumi Nishida, Satomi Omotehara, Shinya Fukushima, Shinsuke Otagiri, Kazunori Nagashima, Reizo Onishi, Ryo Takagi, Yoshito Komatsu, Naoya Sakamoto
Intest Res.2023;21(1):126-136.   Published online 2022 July 22     DOI: http://dx.doi.org/10.5217/ir.2021.00166
      
4 Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study
Hakjun Hyun, Min Joo Choi, Jung Yeon Heo, Yu Bin Seo, Eliel Nham, Jin Gu Yoon, Hye Seong, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim, Ju-Yeon Choi, Young Jae Lee, Hye Won Lee, Sung Soon Kim, Byoungguk Kim, Joon Young Song
J Korean Med Sci.2022;37(27):e210.  Published online 2022 June 28     DOI: http://dx.doi.org/10.3346/jkms.2022.37.e210
      
5 The Occurrence and Management of Adverse Skin Events due to Continuous Glucose Monitoring
Jung Hwa Lee
J Korean Diabetes.2022;23(1):43-49.   Published online 2022 March 31     DOI: http://dx.doi.org/10.4093/jkd.2022.23.1.43
      
6 Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors
Hidefumi Inaba, Yosuke Kaido, Saya Ito, Tomonao Hirobata, Gen Inoue, Takakazu Sugita, Yuki Yamamoto, Masatoshi Jinnin, Hiroaki Kimura, Tomoko Kobayashi, Shintaro Iwama, Hiroshi Arima, Takaaki Matsuoka
Endocrinol Metab.2022;37(1):84-95.   Published online 2022 February 28     DOI: http://dx.doi.org/10.3803/EnM.2021.1282
   
7 한국인 만성 변비 환자에서 프루칼로프라이드의 안전성과 유효성: 시판 후 조사
Sang Eun Yeon, Su Youn Kim, Woo Chul Chung, Seong Woo Jeon, Soo Jung Park, Chang Hwan Choi, Myung Gyu Choi
Korean J Gastroenterol.2021;78(4):219-226.   Published online 2021 October 25     DOI: http://dx.doi.org/10.4166/kjg.2021.099
      
8 Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation
Brigida Barberio, Edoardo Vincenzo Savarino, Timothy Card, Cristina Canova, Francesco Baldisser, Alessandro Gubbiotti, Davide Massimi, Matteo Ghisa, Fabiana Zingone
Intest Res.2022;20(1):114-123.   Published online 2021 August 4     DOI: http://dx.doi.org/10.5217/ir.2021.00037
      
9 Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine
Kyungmin Huh, Yewon Na, Young-Eun Kim, Munkhzul Radnaabaatar, Kyong Ran Peck, Jaehun Jung
J Korean Med Sci.2021;36(27):e197.  Published online 2021 July 2     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e197
      
10 Adrenal insufficiency development during chemotherapy plus anti-programmed death receptor-1 monoclonal antibody (tislelizumab) therapy in patients with advanced gastric cancer: two case reports
Jin Ho Baek
J Yeungnam Med Sci.2021;39(1):62-66.   Published online 2021 April 19     DOI: http://dx.doi.org/10.12701/yujm.2021.00934
      
11 Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System
Minji Jeon, Jehun Kim, Chi Eun Oh, Jin-Young Lee
J Korean Med Sci.2021;36(17):e114.  Published online 2021 April 13     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e114
      
12 Fecal Microbiota Transplantation: Is It Safe?
Seon-Young Park, Geom Seog Seo
Clin Endosc.2021;54(2):157-160.   Published online 2021 March 30     DOI: http://dx.doi.org/10.5946/ce.2021.072
      
13 Predictive Role of Endoscopic Surveillance after Total Gastrectomy with R0 Resection for Gastric Cancer
Jung Su Lee, Jeong Hoon Lee, Jinyoung Kim, Hee Kyong Na, Ji Yong Ahn, Kee Wook Jung, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung
J Korean Med Sci.2021;36(14):e88.  Published online 2021 March 16     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e88
      
14 Estimating Baseline Incidence of Conditions Potentially Associated with Vaccine Adverse Events: a Call for Surveillance System Using the Korean National Health Insurance Claims Data
Kyungmin Huh, Young-Eun Kim, Munkhzul Radnaabaatar, Dae Ho Lee, Dong Wook Kim, Soon-Ae Shin, Jaehun Jung
J Korean Med Sci.2021;36(9):e67.  Published online 2021 February 26     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e67
      
15 Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
Maria Gemelli, Elena Maria Elli, Chiara Elena, Alessandra Iurlo, Tamara Intermesoli, Margherita Maffioli, Ester Pungolino, Maria Cristina Carraro, Mariella D’Adda, Francesca Lunghi, Michela Anghileri, Nicola Polverelli, Marianna Rossi, Mattia Bacciocchi, Elisa Bono, Cristina Bucelli, Francesco Passamonti, Laura Antolini, Carlo Gambacorti-Passerini
Blood Res.2020;55(3):139-145.   Published online 2020 September 30     DOI: http://dx.doi.org/10.5045/br.2020.2020130
      
16 Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Juwhan Choi, Sung Yong Lee
Immune Netw.2020;20(1):e9.  Published online 2020 February 17     DOI: http://dx.doi.org/10.4110/in.2020.20.e9
      
17 Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Juwhan Choi, Sung Yong Lee
Immune Netw.2020;20(1):e9.  Published online 2020 February 4     DOI: http://dx.doi.org/10.4110/in.2020.20.e9
      
18 Immune-related Adverse Events: Overview and Management Strategies for the Use of Immune Checkpoint Inhibitors
Hei-Cheul Jeung, Se Eung Oh, Jee Hung Kim
J Rheum Dis.2019;26(4):221-234.   Published online 2019 October 31     DOI: http://dx.doi.org/10.4078/jrd.2019.26.4.221
   
19 Safety Issues with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical Considerations
Soo Lim
J Korean Diabetes.2019;20(3):127-135.   Published online 2019 September 30     DOI: http://dx.doi.org/10.4093/jkd.2019.20.3.127
      
20 Adverse Events of Tyrosine Kinase Inhibitors in Patients with Advanced Thyroid Cancer
Min Joo Kim, Young Joo Park
Int J Thyroidol.2018;11(2):61-70.   Published online 2018 November 30     DOI: http://dx.doi.org/10.11106/ijt.2018.11.2.61
      

 1 of 2